What is NDC 31722-592?

31722-592 is the product NDC for Metoprolol Succinate, Metoprolol succinate 200 mg/1 tablet, film coated, extended release, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.

Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Metoprolol Succinate?

250 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Metoprolol Succinate NDC 31722-592

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-592Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0592Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
31722-592-01	3172205920131722059201	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-592-01)Marketed from Nov 6, 2020
31722-592-05	3172205920531722059205	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-592-05)Marketed from Apr 23, 2021
31722-592-10	3172205921031722059210	1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-592-10)Marketed from Apr 23, 2021
31722-592-30	3172205923031722059230	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-592-30)Marketed from Nov 6, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Metoprolol Succinate
Generic name (nonproprietary): metoprolol succinate
Active ingredients: Metoprolol succinate — 200 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.NDC labeler code 31722
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205541
Marketing start: Nov 6, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 31722-592_1376704a-04ff-0a4f-e063-6294a90ae9b8SPL ID 1376704a-04ff-0a4f-e063-6294a90ae9b8SPL set ID 74a28333-53c1-493e-b6ad-2192fdc35391RxCUI 866412, 866419, 866427, 866436UNII TH25PD4CCBUPC 0331722591300, 0331722592307, 0331722590303, 0331722589307
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722059201 followed by a unit qualifier and the quantity

Package 31722-0592-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 12, 2024.

Indications (excerpt from the label)

Metoprolol succinate extended-release tablets, are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure ( 1.3 ) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myoca…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 31722-592

What is NDC 31722-592?: 31722-592 is the product NDC for Metoprolol Succinate, Metoprolol succinate 200 mg/1 tablet, film coated, extended release, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Metoprolol Succinate.
What is the active ingredient?: Metoprolol succinate.
Who is the labeler?: Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Metoprolol Succinate?: 250 other product NDCs are listed under this name. See all Metoprolol Succinate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Metoprolol Succinate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Metoprolol Succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-0883	67046-0883-03
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1685	67046-1685-03
Metoprolol Succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1686	67046-1686-03
Metoprolol succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	Oryza pharmaceuticals Inc.	72516-025	72516-0025-0172516-0025-1072516-0025-50
Metoprolol Succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-684	68001-0684-0068001-0684-03
Metoprolol Succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-685	68001-0685-0068001-0685-03
Metoprolol Succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-686	68001-0686-0068001-0686-03
Metoprolol Succinate	Metoprolol succinate 200 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-687	68001-0687-00
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1650	67046-1650-03
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Film coated, Extended releaseOral	Aphena Pharma Solutions - Tennessee, LLC	53401-009	53401-0009-3053401-0009-4553401-0009-53+3 more

All 251 Metoprolol Succinate NDCs

Other NDCs under ANDA 205541

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205541
Product	Strength	Form · route	Labeler	Product NDC
Metoprolol Succinate	Metoprolol succinate 25 mg/1	Tablet, Film coated, Extended releaseOral	Camber Pharmaceuticals, Inc.	31722-589
Metoprolol Succinate	Metoprolol succinate 50 mg/1	Tablet, Film coated, Extended releaseOral	Camber Pharmaceuticals, Inc.	31722-590
Metoprolol Succinate	Metoprolol succinate 100 mg/1	Tablet, Film coated, Extended releaseOral	Camber Pharmaceuticals, Inc.	31722-591
Metoprolol Succinate	Metoprolol succinate 100 mg/1	Tablet, Film coated, Extended releaseOral	Proficient Rx LP	71205-683
Metoprolol Succinate	Metoprolol succinate 50 mg/1	Tablet, Film coated, Extended releaseOral	Proficient Rx LP	71205-724